Pacer Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $420M | Sell |
|
|||||
|
2025
Q2 | $450M | Buy |
|
|||||
|
2025
Q1 | $545M | Sell |
|
|||||
|
2024
Q4 | $560M | Sell |
|
|||||
|
2024
Q3 | $565M | Sell |
|
|||||
|
2024
Q2 | $507M | Buy |
|
|||||
|
2024
Q1 | $496M | Buy |
|
|||||
|
2023
Q4 | $402M | Buy |
|
|||||
|
2023
Q3 | $307M | Buy |
|
|||||
|
2023
Q2 | $258M | Sell |
|
|||||
|
2023
Q1 | $281M | Buy |
|
|||||
|
2022
Q4 | $13.4M | Sell |
|
|||||
|
2022
Q3 | $155M | Buy |
|
|||||
|
2022
Q2 | $149M | Buy |
|
|||||
|
2022
Q1 | $92.2M | Buy |
|
|||||
|
2021
Q4 | $38.6M | Buy |
|
|||||
|
2021
Q3 | $27M | Buy |
|
|||||
|
2021
Q2 | $26M | Buy |
|
|||||
|
2021
Q1 | $16.8M | Buy |
|
|||||
|
2020
Q4 | $16.1M | Buy |
|
|||||
|
2020
Q3 | $14.5M | Buy |
|
|||||
|
2020
Q2 | $11.7M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $17.4M | Sell |
|
|||||
|
2019
Q3 | $14.1M | Buy |
|
|||||
|
2019
Q2 | $11.9M | Buy |
|
|||||
|
2019
Q1 | $6.95M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $9.58M | Buy |
|
|||||
|
2018
Q2 | $7.54M | Buy |
|
|||||
|
2018
Q1 | $3.92M | Buy |
|
|||||
|
2017
Q4 | $3.38M | Buy |
|
|||||
|
2017
Q3 | $2.67M | Buy |
|
|||||
|
2017
Q2 | $2.11M | Buy |
|
|||||
|
2017
Q1 | $1.94M | Buy |
|
|||||
|
2016
Q4 | $1.95M | Sell |
|
|||||
|
2016
Q3 | $1.85M | Sell |
|
|||||
|
2016
Q2 | $2.54M | Buy |
|
|||||
|
2016
Q1 | $2M | Buy |
|
|||||
|
2015
Q4 | $2.03M | Buy |
|
|||||
|
2013
Q4 | $360K | Buy |
|